nvax / Заголовки новостей 
NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UK
Coinspeaker NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UKFollowing the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0. дальше »
2020-9-26 17:16
|